Aprotinin
Aprotinin
BPTI sequence ribbon sticks
Aprotinin[edit | edit source]
Aprotinin is a serine protease inhibitor derived from bovine lung tissue. It is used in medicine to reduce bleeding during complex surgeries, such as cardiac surgery. Aprotinin works by inhibiting several proteolytic enzymes, including trypsin, plasmin, and kallikrein.
Mechanism of Action[edit | edit source]
Aprotinin functions by forming reversible stoichiometric complexes with proteases, thereby inhibiting their activity. This inhibition is particularly effective against plasmin, an enzyme involved in the breakdown of fibrin, which is a key component of blood clots. By inhibiting plasmin, aprotinin helps to maintain clot stability and reduce bleeding.
Clinical Uses[edit | edit source]
Aprotinin has been primarily used in cardiopulmonary bypass surgeries to reduce perioperative blood loss and the need for blood transfusions. It has also been used in other surgical procedures where significant bleeding is anticipated.
Safety and Efficacy[edit | edit source]
The use of aprotinin has been controversial due to concerns about its safety profile. Some studies have suggested an increased risk of renal failure, myocardial infarction, and stroke associated with its use. As a result, aprotinin was temporarily withdrawn from the market in some countries but has since been reintroduced with specific guidelines and restrictions.
Pharmacokinetics[edit | edit source]
Aprotinin is administered intravenously and has a rapid onset of action. It is distributed in the extracellular space and is primarily eliminated by the kidneys. The half-life of aprotinin is approximately 150 minutes, but this can vary depending on the patient's renal function.
History[edit | edit source]
Aprotinin was first isolated in the 1930s and was introduced into clinical practice in the 1960s. It gained widespread use in the 1980s and 1990s for its ability to reduce bleeding during surgery. However, its use declined in the late 2000s due to safety concerns, leading to a reevaluation of its risk-benefit profile.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
